From the Journals

Albumin Therapy Tested in Septic Shock

Multicenter randomized study finds similar mortality and organ failure outcomes with albumin therapy and standard fluid care

Share

  • 1

    440 adults with septic shock participated in the trial.

  • 2

    No significant reduction in mortality with albumin therapy compared to standard fluid management.

  • 3

    90-day mortality was 43% in albumin group vs. 46% in control.

  • 4

    Safety outcomes were similar between groups.

  • 5

    Need for further studies to identify potential benefits in specific subgroups.

Original Source(s)

Albumin Therapy Tested in Septic Shock

Multicenter randomized study finds similar mortality and organ failure outcomes with albumin therapy and standard fluid care

  • by Henry Thomas

  • March 4, 2026

  • 3 min

Related Content

Sepsis Antibiotic Timing Shows Physician Divide

Emergency department physicians differ in how quickly they initiate antibiotics for suspected sepsis.

Pneumonia Patterns Postpandemic

Pneumococcal and RSV RAD-CAP incidence increased as SARS-CoV-2 incidence declined, disproportionately affecting older adults.

Leukemia Case Prompts Broader Review

Researchers assess hematologic malignancies temporally associated with mRNA COVID-19 vaccination.